logo

Achaogen Inc. (AKAO)



Trade AKAO now with
  Date
  Headline
11/12/2018 6:28:29 AM Wedbush Is Cutting Achaogen Inc. (AKAO) FY18 Rev. Estimate To 8.9 M From 12.4 M
11/12/2018 6:28:15 AM Wedbush Is Lowering Achaogen Inc. (AKAO) Q4 18 Rev. Estimate To 2.2 M From 4.5 M
11/12/2018 6:27:46 AM Wedbush Is Increasing Achaogen Inc. (AKAO) FY18 Estimate To -3.82 From -4.12
11/12/2018 6:27:28 AM Wedbush Is Raising Achaogen Inc. (AKAO) Q4 18 Estimate To -0.71 From -0.74
11/12/2018 6:27:04 AM Wedbush Cuts Achaogen Inc. (AKAO) To Neutral From Outperform With $3 Down From $17 Price Target
11/8/2018 8:14:44 AM Achaogen Q3 Loss Per Share $1.02 Vs Loss $0.85 Last Year
10/17/2018 8:03:55 AM Achaogen Submits Marketing Authorization Application To EMA For Plazomicin
8/9/2018 9:14:18 AM Wedbush Is Lowering Achaogen Inc. (AKAO) FY18 Estimate To -4.12 From -3.65
8/9/2018 9:14:02 AM Wedbush Is Increasing Achaogen Inc. (AKAO) Q4 18 Estimate To -0.74 From -0.82
8/9/2018 9:13:50 AM Wedbush Is Cutting Achaogen Inc. (AKAO) Q3 18 Estimate To -1.20 From -0.82
7/16/2018 6:47:42 AM New Drugs Approved In June
6/26/2018 8:40:10 AM ZEMDRI Approved By FDA For Treatment Of Adults With Complicated Urinary Tract Infections
6/26/2018 8:10:12 AM Achaogen: FDA Approves ZEMDRI For Adults With Complicated Urinary Tract Infections
6/26/2018 8:09:19 AM Achaogen, Trading Expected To Resume At 8:30 AM ET
6/26/2018 8:08:24 AM Achaogen, Trading Halt Pending News